UBS O'Connor’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $152K | Buy |
80,000
+71,580
| +850% | +$136K | 0.01% | 258 |
|
|
2025
Q1 | $59.6K | Sell |
8,420
-33,725
| -80% | -$239K | ﹤0.01% | 233 |
|
|
2024
Q4 | $928K | Sell |
42,145
-9,500
| -18% | -$209K | 0.02% | 230 |
|
|
2024
Q3 | $1.04M | Buy |
51,645
+12,961
| +34% | +$260K | 0.03% | 270 |
|
|
2024
Q2 | $673K | Sell |
38,684
-5,833
| -13% | -$101K | 0.02% | 341 |
|
|
2024
Q1 | $1.86M | Sell |
44,517
-13,584
| -23% | -$566K | 0.05% | 184 |
|
|
2023
Q4 | $1.46M | Buy |
58,101
+6,101
| +12% | +$154K | 0.05% | 219 |
|
|
2023
Q3 | $1.7M | Buy |
52,000
+37,000
| +247% | +$1.21M | 0.03% | 263 |
|
|
2023
Q2 | $873K | Buy |
+15,000
| New | +$873K | 0.02% | 391 |
|